KYMR
Kymera Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KYMR Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-04
Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-04 · Earnings Call
Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call Transcript
2025-11-04
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-04 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-04
Form 8-K - Current report
Key Events
2025-11-04 · Key Events
Form 8-K - Current report
2025-10-29
Form 144 - Report of proposed sale of securities
Ownership
2025-10-29 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-15
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-15 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-15
Form 144 - Report of proposed sale of securities
Ownership
2025-10-15 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-14
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-14 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
